Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Taub Rebecca
Director at MADRIGAL PHARMACEUTICALS. Filing since 11 Jun 2018.
CIK 0001423898
Company
Date
Role
Action
Shares
Amount
Of holding
MDGL
MADRIGAL PHARMACEUTICALS, INC.
6 Mar 2026
Director
Sold at will
491
$212.08K
0.1%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
26 Jan 2026
Director
Sold at will
647
$318.60K
0.1%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
20 Jan 2026
Director
Sold at will
2,238
$1.10M
0.5%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
9 Jan 2026
Director
Sold on a plan
18,650
$9.75M
3.9%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
10 Dec 2025
Director
Sold on a plan
18,650
$10.30M
3.9%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
12 Aug 2025
Director
Sold on a plan
43,263
$15.39M
8.6%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
11 Aug 2025
Director
Sold on a plan
3,200
$1.12M
0.7%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
18 Jul 2025
Director
Sold on a plan
1,000
$350.01K
0.2%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
17 Jul 2025
Director
Sold on a plan
2,657
$931.03K
0.6%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
16 Jul 2025
Director
Sold on a plan
26,444
$9.35M
5.4%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
24 Jan 2025
Pres., R&D, and CMO
Sold at will
648
$217.24K
0.1%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
17 Jan 2025
Pres., R&D, and CMO
Sold at will
1,689
$461.79K
0.4%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
8 Apr 2024
Pres., R&D, and CMO
Sold on a plan
2,676
$658.26K
0.6%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
5 Apr 2024
Pres., R&D, and CMO
Sold on a plan
27,506
$6.69M
5.7%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
4 Apr 2024
Pres., R&D, and CMO
Sold on a plan
18,537
$4.50M
3.9%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
3 Apr 2024
Pres., R&D, and CMO
Sold on a plan
27,845
$6.83M
5.7%
MDGL
MADRIGAL PHARMACEUTICALS, INC.
11 Jun 2018
Chief Medical Officer, EVP R&D
Bought
73,526
$21.14M
12.6%
17 decisions on file.
